Another thing to think about is the broad appeal of the products you offer. There are a lot of funky CBD products out there. I've seen items like CBD cookies and CBD spices sell very poorly. I recommend staying mainstream with the products you sell. Choose a brand that offers tinctures, softgels, salves, and other products your customers have experience with.
Real Scientific Hemp Oil touts itself as being somewhat of a pioneer, as – according to the company – its own variety of CBD oil was the first to hit the mainstream back in 2012. In addition, the brand claims that its RSHO-X CBD liquid is the earliest no-THC product of its kind, making it a sound choice for those worried about whether CBD oil use will influence the results of drug tests. The company is also transparent about the processes that go into making its varieties of CBD-containing hemp oils, helping customers make informed choices as to which of its products are best for them. And minds may be put at ease upon learning that Real Scientific Hemp Oil tests its CBD oil three times – a process which seems to speak to the quality, purity and safety of the provider’s wares.
A complicated question. Only CBD oil sold by MMPR registered companies is legal for sale inside of Canada. However, this oil is often in low supply and of low quality due to inexperience and a heavily over-regulated federal system that is not conducive to the production of good product at a decent price. Funnily enough, the companies with the most experience and best track record for making quality CBD oil have been those selling their product in Canada’s “grey area” dispensary market, as they have been doing so for over a decade while the federal program has only been allowed to sell concentrates for the passed year.
It’s fair to say that the CBD market is thriving. According to market intelligence company Hemp Business Journal, $130 million worth of products containing the cannabinoid were bought in the U.S. in 2016. And that figure is only set to rise in the years to come, the data analyst believes. Indeed, the source estimates that consumer sales of CBD goods will total an astounding $2.1 billion by 2020 – buoyed, perhaps, by claims that the usage of such products can help alleviate the symptoms of chronic pain, depression and diabetes, to name but a few conditions.